Alcoholic hepatitis natural history, complications and prognosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 3: | Line 3: | ||
{{CMG}}; '''Assosciate Editor(s)-In-Chief:''' [[User: Prashanthsaddala|Prashanth Saddala M.B.B.S]] | {{CMG}}; '''Assosciate Editor(s)-In-Chief:''' [[User: Prashanthsaddala|Prashanth Saddala M.B.B.S]] | ||
== Overview== | |||
==Natural history, complication, and prognosis== | |||
=== Natural history=== | |||
*[[Alcoholic]] [[liver disease]] may progress to one of the following stages:<ref name="pmid18613369">{{cite journal| author=Testino G| title=Alcoholic diseases in hepato-gastroenterology: a point of view. | journal=Hepatogastroenterology | year= 2008 | volume= 55 | issue= 82-83 | pages= 371-7 | pmid=18613369 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18613369 }} </ref> <ref name="pmid23904876">{{cite journal| author=Testino G| title=Alcoholic hepatitis. | journal=J Med Life | year= 2013 | volume= 6 | issue= 2 | pages= 161-7 | pmid=23904876 | doi= | pmc=3725441 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23904876 }} </ref> | |||
**[[Fatty liver]] or [[ hepatic]][[steatosis]] | |||
**[[Steatohepatitis]] defined as [[Alcoholic Hepatitis]] or [[alcoholic]] [[steatonecrosis]] | |||
** [[Fibrosis]] | |||
** [[Cirrhosis]] and [[hepatocellular carcinoma]] ([[HCC]]) | |||
* The [[liver]] [[biopsy]] of around 20-40% of the individuals with [[steatosis]] is suggestive of [[steatohepatitis]] | |||
* After development of [[steatohepatitis]], the [[hepatic]] change is irreversible, even after the abstinence | |||
* Compared to [[steatosis]], development of [[Alcoholic Hepatitis]] in subjects with [[alcoholic liver disease]] is accompanied nine -times higher risk of developing [[cirrhosis]] as well as 40 % chance of 180- days mortality.<ref name="pmid21317995">{{cite journal| author=Frazier TH, Stocker AM, Kershner NA, Marsano LS, McClain CJ| title=Treatment of alcoholic liver disease. | journal=Therap Adv Gastroenterol | year= 2011 | volume= 4 | issue= 1 | pages= 63-81 | pmid=21317995 | doi=10.1177/1756283X10378925 | pmc=3036962 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21317995 }} </ref> | |||
==Prognosis== | ==Prognosis== | ||
* Poor prognostic factors include: | * Poor prognostic factors include: | ||
Revision as of 17:17, 30 July 2021
|
Alcoholic hepatitis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Alcoholic hepatitis natural history, complications and prognosis On the Web |
|
American Roentgen Ray Society Images of Alcoholic hepatitis natural history, complications and prognosis |
|
FDA on Alcoholic hepatitis natural history, complications and prognosis |
|
CDC on Alcoholic hepatitis natural history, complications and prognosis |
|
Alcoholic hepatitis natural history, complications and prognosis in the news |
|
Blogs on Alcoholic hepatitis natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Assosciate Editor(s)-In-Chief: Prashanth Saddala M.B.B.S
Overview
Natural history, complication, and prognosis
Natural history
- Alcoholic liver disease may progress to one of the following stages:[1] [2]
- Fatty liver or hepaticsteatosis
- Steatohepatitis defined as Alcoholic Hepatitis or alcoholic steatonecrosis
- Fibrosis
- Cirrhosis and hepatocellular carcinoma (HCC)
- The liver biopsy of around 20-40% of the individuals with steatosis is suggestive of steatohepatitis
- After development of steatohepatitis, the hepatic change is irreversible, even after the abstinence
- Compared to steatosis, development of Alcoholic Hepatitis in subjects with alcoholic liver disease is accompanied nine -times higher risk of developing cirrhosis as well as 40 % chance of 180- days mortality.[3]
Prognosis
- Poor prognostic factors include:
- Ascites
- Elevated bilirubin
- Elevated [prothrombin time]] (PT)
- Encephalopathy
- Hepatic fibrosis and cirrhosis
- Leukocytosis not due to other causes
- Renal failure
- Discriminant function, as described above, is a predictor or severity.
- DF > 32 – Mortality 35% without steroids, in patients without encephalopathy. Mortality 45% in patients with encephalopathy.
- Abstinence appears to help slow or stop the progression of alcohol associated liver disease.
- In patients with advanced disease, cirrhosis can develop in patients who stop, but is much more likely to develop in those patients who continue to drink.
- Maddrey, et al #maddrey described the Discriminant Function (DF) formula to determine patients who might respond:
- DF = 4.6 x (PT – control PT) + Total Bilirubin
- DF > 32 has been been associated with a high death rate, up to 50% in some studies, with improved prognosis with steroid treatment.
- A recent study showed a fall in one month mortality from 35 to 6%. Another showed a fall in six month mortality 55 to 16%.
- Effect on long term mortality not clear
References
- ↑ Testino G (2008). "Alcoholic diseases in hepato-gastroenterology: a point of view". Hepatogastroenterology. 55 (82–83): 371–7. PMID 18613369.
- ↑ Testino G (2013). "Alcoholic hepatitis". J Med Life. 6 (2): 161–7. PMC 3725441. PMID 23904876.
- ↑ Frazier TH, Stocker AM, Kershner NA, Marsano LS, McClain CJ (2011). "Treatment of alcoholic liver disease". Therap Adv Gastroenterol. 4 (1): 63–81. doi:10.1177/1756283X10378925. PMC 3036962. PMID 21317995.